Organovo delivers 3D Liver tissue ahead of schedule; shares jump

• Organovo (NASDAQ:ONVO) has delivered the first 3D Liver tissue to a laboratory outside of the company to a "key opinion leader" for experimentation.
• The target date for the milestone had been April; Organovo expects to have bioprinted almost 400 3D Liver tissues during January.
• Organovo also intends to launch its 3D Liver tissue product and generate revenues before December; previously, the company's target had been the end of that month.
• Shares +6.7%.  (8-K)